February 2026 Update on US regulatory review of Saphnelo subcutaneous administration in systemic lupus erythematosus The US Food and Drug Administration (FDA) issued a complete response letter (CRL) ...

China’s Ministry of Foreign Affairs (MOFA) on December 26, 2025, issued the country’s latest round of sanctions pursuant to its Anti-Foreign ...

More than 90% of drugs that appear safe and effective in animal studies ultimately fail once they reach human trials, and the consequences are staggering: billions of dollars wasted, delays in new ...

The 2026 Report is the final installment in a trilogy on development through uncertainty, building on the 2023–24 HDR on political polarization and the 2025 HDR on AI-driven transformations. This ...

This study on Bangladesh was undertaken to analyze the gender dimensions of climate change and the role of institutions in reducing gender gaps. The study was carried out in 20 sites covering 600 ...

Viet Nam’s investment in its youngest generation is fundamentally an investment in the country’s future human capital. Today, over 10 million Vietnamese children under age 6 (with another one million ...

In experiments with mice, Johns Hopkins Medicine scientists report new evidence that precursors of myelin-producing cells—one of the few brain cell types that continue to be produced in the adult ...

Takeda (TSE:4502/NYSE:TAK) today announced the U.S. availability of GAMMAGARD LIQUID™ ERC [immune globulin infusion (human)] ...

Security teams often spend days manually turning long incident reports and threat writeups into actionable detections by ...

The autonomous driving market is experiencing explosive growth, powered by rapid advancements in artificial intelligence (AI) ...

ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, showing best-in-class potential for ...